Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Labeling errors & mix-ups

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose.

1,411 FDA drug recalls with this cause, newest first.

This is exactly what it sounds like: the wrong label on the right product, the wrong strength printed on the bottle, a missing or illegible lot number and expiry date, or two products mixed up during packaging. It is dangerous precisely because the pill or liquid itself may be fine, yet the patient has no way of knowing what they are actually taking. A high share of the Class I recalls in this group are mix-ups where a stronger product ended up in a weaker product's packaging.

Class II · Moderate risk

N-A-C

Mislabeling of SUS (N-A-C Sustain 600 mg 100 tab) with N-A-C N-Acetyl-L-Cysteine 500 mg, 100 cap.

Terminated Labeling / mix-up Jarrow Formulas Inc D-0302-2021
Class III · Low risk

Dextroamphetamine Saccharate

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Terminated Labeling / mix-up ANI Pharmaceuticals, Inc. NDC 43975-282-10 D-0048-2021
Class III · Low risk

Dextroamphetamine Saccharate

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Terminated Labeling / mix-up ANI Pharmaceuticals, Inc. NDC 43975-281-10 D-0047-2021
Class III · Low risk

Dextroamphetamine Saccharate

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Terminated Labeling / mix-up ANI Pharmaceuticals, Inc. NDC 43975-280-10 D-0046-2021
Class III · Low risk

Dextroamphetamine Saccharate

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Terminated Labeling / mix-up ANI Pharmaceuticals, Inc. NDC 43975-279-10 D-0045-2021
Class III · Low risk

Dextroamphetamine Saccharate

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Terminated Labeling / mix-up ANI Pharmaceuticals, Inc. NDC 43975-278-10 D-0044-2021
Class III · Low risk

Dextroamphetamine Saccharate

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Terminated Labeling / mix-up ANI Pharmaceuticals, Inc. NDC 43975-277-10 D-0043-2021
Class I · High risk

Smart Care HAND SANITIZER

Labeling: Not Elsewhere Classified. Container packaging is made, formed or filled to be misleading, resembling food and drink pouches

Terminated Labeling / mix-up Ashtel Studios, INC. NDC 70108-042-01 D-0098-2021
Class II · Moderate risk

Killz Germz Hand Sanitizer

Sub-Potent Drug; Killz GERMz was recalled due to sub-potent results. Testing revealed ethanol levels as low as 62% while labelled claim is 70%.

Ongoing Labeling / mix-up Genesis Partnership Company SA NDC 74625-003-05 D-0041-2021
Class II · Moderate risk

Killz Germz Hand Sanitizer

Sub-Potent Drug; Killz GERMz was recalled due to sub-potent results. Testing revealed ethanol levels as low as 62% while labelled claim is 70%.

Ongoing Labeling / mix-up Genesis Partnership Company SA NDC 74625-003-04 D-0040-2021
Class III · Low risk

Nicotine Gum

Labeling: Incorrect or Missing Package Insert: The package insert included in the finished product is for the Canadian market and is not part of the current approved drug labeling.

Terminated Labeling / mix-up P & L Developments, LLC NDC 11822-3328-3 D-0004-2021
Class I · High risk

Tranexamic Acid Injection

Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.

Terminated Labeling / mix-up Mylan Institutional LLC NDC 67457-197-00 D-1576-2020
Class I · High risk

Amiodarone Hydrochloride Injection

Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.

Terminated Labeling / mix-up Mylan Institutional LLC NDC 67457-153-99 D-1575-2020
Class II · Moderate risk

Prednisone Tablets

Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg

Terminated Labeling / mix-up Lannett Company, Inc. NDC 0527-2931-37 D-1508-2020
Class II · Moderate risk

Just Hand Sanitizer

Labeling Not Elsewhere Classified: Product labeled to contain methanol

Terminated Labeling / mix-up Open Book Extracts NDC 78065-2020-2 D-1564-2020
Class III · Low risk

Red Cross Oral Pain

Labeling; Not Elsewhere Classified: The Mentholatum Company is initiating a voluntary recall due to an error in the labeling of the cotton pellet box found within the Red Cross Oral Pain blister pack. The cotton pellet box states that the product contains "Natural Eugenol Oil" in which it does not.

Terminated Labeling / mix-up The Mentholatum Company NDC 10742-8902-1 D-1541-2020
Class II · Moderate risk

Lidocaine Patch 5%

Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.

Terminated Labeling / mix-up Teva Pharmaceuticals USA NDC 0591-3525-30 D-1492-2020
Class III · Low risk

Fosaprepitant for Injection

Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual amount of 18.8 mg / vial.

Terminated Labeling / mix-up Fresenius Kabi USA, LLC NDC 63323-972-10 D-1391-2020
Class III · Low risk

Nabumetone Tablets

Labeling Not Elsewhere Classified: The statement Pharmacist: Dispense with the accompanying Medication Guide was not included on the carton label.

Terminated Labeling / mix-up American Health Packaging D-1372-2020